Cargando…
Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration
Precision medicine aims to improve patient care by adjusting medication to each patient’s individual needs. Age-related macular degeneration (AMD) is a heterogeneous eye disease in which several pathways are involved, and the risk factors driving the disease differ per patient. As a consequence, pre...
Autores principales: | Lorés-Motta, Laura, de Jong, Eiko K., den Hollander, Anneke I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954014/ https://www.ncbi.nlm.nih.gov/pubmed/29700787 http://dx.doi.org/10.1007/s40291-018-0332-1 |
Ejemplares similares
-
Risk factors for progression of age‐related macular degeneration
por: Heesterbeek, Thomas J, et al.
Publicado: (2020) -
The Effect of Genetic Variants Associated With Age-Related Macular Degeneration Varies With Age
por: Schick, Tina, et al.
Publicado: (2020) -
A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration
por: Lorés-Motta, Laura, et al.
Publicado: (2016) -
The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment
por: Geerlings, Maartje J., et al.
Publicado: (2017) -
Analysis of hemopexin plasma levels in patients with age-related macular degeneration
por: Lauwen, Susette, et al.
Publicado: (2022)